中英文說(shuō)明書丨艾美捷環(huán)丁烷嘧啶二聚體CPD介紹
DNA damage factors commonly existing in the internal and external environment of cells will destroy the stability of genetic information. One of the mechanisms of UV damage to skin is to damage the DNA of cells, form "sunburn cells", and induce rich variations of DNA in cells, mainly including cyclobutane pyrimidine dimer (CPD), 6-4 photoproducts (6-4PPs) and their isomers, which is one of the main reasons for inducing DNA damage!
?
Synonyms:
Cyclobutane pyrimidine dimer (CPD)
Specificity:
Reacts specifically with thymine dimers produced by
UV irradiation in double- or single-stranded DNA.
Does not react with (6-4) photo products.
Ig Isotype:
Mouse IgG1
Immunogen:
UV-irradiated salmon sperm DNA
Hybridoma:
Mouse myeloma (P3/X63-Ag8) x immunized mouse
(Balb/c) splenocytes.
Format:
200 μL of 0.5 mg/mL purified monoclonal antibody in
PBS with protein stabilizer and 0.1% sodium azide.
Purified by Protein A chromatography.
Storage:
Store at 4°C for short term, store at?–20°C for long
term. Avoid repeat freeze/thaw cycles.
?
一起來(lái)了解一下眾多Nature文章使用認(rèn)證的Kamiya艾美捷環(huán)丁烷嘧啶二聚體CPD。環(huán)丁烷嘧啶二聚體CPD也稱作抗胸腺嘧啶二聚體單抗,克隆KTM53。
?
Kamiya艾美捷環(huán)丁烷嘧啶二聚體CPD相關(guān)性質(zhì):
同義詞:抗胸腺嘧啶二聚體單抗,克隆KTM53
特異性:與由以下物質(zhì)產(chǎn)生的胸腺嘧啶二聚體發(fā)生特異性反應(yīng):雙鏈或單鏈DNA的紫外線照射。不與(6-4)照片產(chǎn)品反應(yīng)。
Ig同種型:小鼠IgG1
免疫原:紫外線照射三文魚精子DNA
雜交瘤:小鼠骨髓瘤(P3/X63-Ag8)x免疫小鼠(Balb/c)脾細(xì)胞。
格式:200μL 0.5 mg/mL純化單克隆抗體PBS,含蛋白質(zhì)穩(wěn)定劑和0.1%疊丨氮丨化鈉。通過(guò)蛋白質(zhì)A色譜純化。
存儲(chǔ):短期儲(chǔ)存在4°C,長(zhǎng)期儲(chǔ)存在-20°C學(xué)期避免重復(fù)冷凍/解凍循環(huán)。
應(yīng)用和建議的稀釋液:n
原位雜交:以1:40至1:80的比例使用稀釋。稀釋系數(shù)取決于應(yīng)用固定組織的冰凍切片或福爾馬林固定石蠟包埋切片推薦。(由最終用戶發(fā)布。)
DNA印跡:用于檢測(cè)胸腺嘧啶紫外線損傷DNA和胸腺嘧啶化DNA探針中的二聚體。
?
Kamiya艾美捷環(huán)丁烷嘧啶二聚體CPD(抗胸腺嘧啶二聚體單抗)示例數(shù)據(jù):
?

僅用于體外研究。不適用于診斷或人類。
環(huán)丁烷嘧啶二聚體CPD(抗胸腺嘧啶二聚體單抗)Nature發(fā)表文章:
【Nature,IF=69.5】Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells
誘導(dǎo)多能干?(iPS)?細(xì)胞的產(chǎn)生使患者特異性多能細(xì)胞的衍生成為可能,并為模擬人類疾病提供了有價(jià)值的實(shí)驗(yàn)平臺(tái)。患者特異性?iPS?細(xì)胞也被認(rèn)為具有巨大的治療潛力,盡管這方面的直接證據(jù)仍然缺乏。在糾正遺傳缺陷后,范可尼貧血患者的體細(xì)胞可以重新編程為多能性,以產(chǎn)生患者特異性的?iPS?細(xì)胞。這些細(xì)胞系似乎與人類胚胎干細(xì)胞和健康個(gè)體的?iPS?細(xì)胞無(wú)法區(qū)分。重要的是,校正后的范可尼貧血特異性?iPS?細(xì)胞可以產(chǎn)生表型正常(即無(wú)病)的骨髓和紅細(xì)胞譜系的造血祖細(xì)胞。這些數(shù)據(jù)提供了概念驗(yàn)證,即?iPS?細(xì)胞技術(shù)可用于生成具有細(xì)胞治療應(yīng)用潛在價(jià)值的疾病校正、患者特異性細(xì)胞